During the past decade, Charles River Eye Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Charles River Eye Associates" are "Blepharitis" (1 trials), "Dry Eye" (1 trials), "Dry Eye Syndrome" (1 trials) and "Meibomian Gland Dysfunction" (1 trials). Many other conditions were trialed in "Charles River Eye Associates" in a lesser frequency.

Most popular intervention types in "Charles River Eye Associates" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "LipiFlow Post-treatment" (1 trials), "LipiFlow Pre-Treatment" (1 trials), "LipiFlow System" (1 trials) and "Warm Compress Therapy + Lid Scrub" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charles River Eye Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Charles River Eye Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Charles River Eye Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charles River Eye Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".